НовостиBenzingaWedbush Initiates Coverage On Korsana Biosciences with Outperform Rating, Announces Price Target of $44 Wedbush Initiates Coverage On Korsana Biosciences with Outperform Rating, Announces Price Target of $44 Benzinga 2026.10.05 17:00 (GMT+0) Открыть на Benzinga Другие новости